155 related articles for article (PubMed ID: 8778479)
1. [Chronic persistent coughing successfully treated with ozagrel].
Nishi K; Mizuguchi M; Tachibana H; Ooka T; Fujimura M; Matsuda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):350-4. PubMed ID: 8778479
[TBL] [Abstract][Full Text] [Related]
2. [Effects of a thromboxane-synthetase inhibitor in patients with chronic persistent coughing and no airwayhyperresponsiveness].
Nishi K; Mizuguchi M; Tachibana H; Watanabe K; Ooka T; Fujimura M; Matsuda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Sep; 35(9):927-33. PubMed ID: 9396248
[TBL] [Abstract][Full Text] [Related]
3. Participation of thromboxane A(2) in the cough response in guinea-pigs: antitussive effect of ozagrel.
Shinagawa K; Kojima M; Ichikawa K; Hiratochi M; Aoyagi S; Akahane M
Br J Pharmacol; 2000 Sep; 131(2):266-70. PubMed ID: 10991919
[TBL] [Abstract][Full Text] [Related]
4. [Thromboxane A2 synthetase inhibitor in asthma therapy].
Machida K; Takagi K; Horiba M
Nihon Rinsho; 1996 Nov; 54(11):3034-9. PubMed ID: 8950950
[TBL] [Abstract][Full Text] [Related]
5. [A case of chronic persistent cough caused by gastro-esophageal reflux].
Nishi K; Amemiya T; Mizuguchi M; Ooka T; Fujimura M; Matsuda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):652-9. PubMed ID: 7666622
[TBL] [Abstract][Full Text] [Related]
6. [Cough-variant asthma successfully treated with a peptide leukotriene receptor antagonist].
Nishi K; Watanabe K; Ooka T; Fujimura M; Matsuda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):117-23. PubMed ID: 9071168
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors.
Umemura K; Nakashima M; Saruta T
Life Sci; 1997; 60(18):1583-8. PubMed ID: 9126880
[TBL] [Abstract][Full Text] [Related]
8. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
[No Abstract] [Full Text] [Related]
9. Treatment of branch retinal arterial occlusion with sodium ozagrel, a thromboxane A2 synthetase inhibitor.
Kato H; Emura S; Takeuchi N; Enoki M; Oogushi K; Takashima T; Ohmori K; Saito I
J Int Med Res; 1997; 25(2):108-11. PubMed ID: 9100166
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effects of urokinase and sodium ozagrel in patients with acute symptomatic lacunar infarction].
Sakamoto T; Harimoto K; Inoue S; Konishi A
No To Shinkei; 1996 Sep; 48(9):805-9. PubMed ID: 8888028
[TBL] [Abstract][Full Text] [Related]
11. [Highlights of thromboxane synthetase inhibitor research].
Yu WG; Xu LN
Sheng Li Ke Xue Jin Zhan; 1990 Jul; 21(3):216-20. PubMed ID: 2244198
[No Abstract] [Full Text] [Related]
12. [Chronic cough].
Im Hof V
Ther Umsch; 1992 Oct; 49(10):684-91. PubMed ID: 1440436
[TBL] [Abstract][Full Text] [Related]
13. [Chronic arterial occlusive diseases--drug therapy and thromboxane A2 synthetase inhibitor].
Yasuda K; Matsui Y; Goda T; Sakuma M; Go K
Nihon Rinsho; 1991 Sep; 49(9):2149-54. PubMed ID: 1960880
[No Abstract] [Full Text] [Related]
14. Stretch-induced contraction of rabbit isolated pulmonary artery and the involvement of endothelium-derived thromboxane A2.
Nakayama K; Ueta K; Tanaka Y; Tanabe Y; Ishii K
Br J Pharmacol; 1997 Sep; 122(2):199-208. PubMed ID: 9313926
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor].
Okamoto S; Yonekawa Y; Handa H; Handa Y; Uemura Y; Yano I; Toyoshima M; Iwatsuji K; Teraura T; Yamagata S
Nihon Geka Hokan; 1986 Jan; 55(1):251-9. PubMed ID: 3741043
[No Abstract] [Full Text] [Related]
16. Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
Teraoka S; Takahashi K; Toma H; Sanaka T; Yamaguchi Y; Tanabe K; Sato H; Kawaguchi H; Oba S; Nakajima I
Transplant Proc; 1987 Oct; 19(5):3664-8. PubMed ID: 3313883
[No Abstract] [Full Text] [Related]
17. Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma.
Kurosawa M
Clin Ther; 1995; 17(1):2-11; discussion 1. PubMed ID: 7758058
[TBL] [Abstract][Full Text] [Related]
18. Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents.
Aliprandi P; Castelli C; Bernorio S; Dell'Abate E; Carrara M
Drugs Exp Clin Res; 2004; 30(4):133-41. PubMed ID: 15553659
[TBL] [Abstract][Full Text] [Related]
19. [Clinical effects of sodium ozagrel and urokinase in patients with acute cerebral infarction in the territory of the internal carotid artery].
Itoh H; Yamatani K; Oshida N; Shioi M; Takaba M; Kamiyama H; Itoh M
No To Shinkei; 1998 Feb; 50(2):147-55. PubMed ID: 9513204
[TBL] [Abstract][Full Text] [Related]
20. [Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor].
Katoh K; Kani H; Imai T
Masui; 1985 Jul; 34(7):966-72. PubMed ID: 4057547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
